Literature DB >> 2272027

In vitro and in vivo evaluation of US-NCI compounds in human tumor xenografts.

H H Fiebig1, D P Berger, B R Winterhalter, J Plowman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2272027     DOI： 10.1016/0305-7372(90)90034-d

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  17 in total

1.  Inhibition of liver, kidney, and intestine regeneration by rapamycin.

Authors:  A Francavilla; T E Starzl; C Scotti; G Carrieri; A Azzarone; Q H Zeng; K A Porter; S L Schreiber
Journal:  Transplantation       Date:  1992-02       Impact factor: 4.939

Review 2.  Endocrine resistance in breast cancer: focus on the phosphatidylinositol 3-kinase/akt/mammalian target of rapamycin signaling pathway.

Authors:  Shira Peleg Hasson; Tami Rubinek; Larysa Ryvo; Ido Wolf
Journal:  Breast Care (Basel)       Date:  2013-08       Impact factor: 2.860

3.  Reversal effect of ouabain on multidrug resistance in esophageal carcinoma EC109/CDDP cells by inhibiting the translocation of Wnt/β-catenin into the nucleus.

Authors:  Yucheng Shen; Qinghua Wang; Ye Tian
Journal:  Tumour Biol       Date:  2016-10-05

4.  Mutational analysis of the PTEN gene and its effects in esophageal squamous cell carcinoma.

Authors:  Guiqin Hou; Zhaoming Lu; Mingyue Liu; Hongmin Liu; Lexun Xue
Journal:  Dig Dis Sci       Date:  2010-11-30       Impact factor: 3.199

5.  A retroinhibition approach reveals a tumor cell-autonomous response to rapamycin in head and neck cancer.

Authors:  Panomwat Amornphimoltham; Vyomesh Patel; Kantima Leelahavanichkul; Robert T Abraham; J Silvio Gutkind
Journal:  Cancer Res       Date:  2008-02-15       Impact factor: 12.701

6.  Acute effects of 4-ipomeanol on experimental lung tumors with bronchiolar or alveolar cell features in Syrian hamsters or C3H/HeNCr mice.

Authors:  S Rehm; D E Devor
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

7.  Pyrazine diazohydroxide (NSC-361456). Phase I clinical and pharmacokinetic studies.

Authors:  M V Dhodapkar; R L Richardson; J M Reid; M M Ames
Journal:  Invest New Drugs       Date:  1994       Impact factor: 3.850

8.  ScFKBP12 bridges rapamycin and AtTOR in Arabidopsis.

Authors:  Rui Zhang; Zhigang Meng; Tao Zhou; Yong Deng; Li Feng; Yuan Wang; Guoqing Sun; Sandui Guo; Maozhi Ren
Journal:  Plant Signal Behav       Date:  2013-08-29

9.  Tissue microarrays of human tumor xenografts: characterization of proteins involved in migration and angiogenesis for applications in the development of targeted anticancer agents.

Authors:  Victoria Smith; Gregory J Wirth; Heinz-Herbert Fiebig; Angelika M Burger
Journal:  Cancer Genomics Proteomics       Date:  2008 Sep-Oct       Impact factor: 4.069

10.  Overexpression of ROD1 inhibits invasion of breast cancer cells by suppressing the translocation of β-catenin into the nucleus.

Authors:  Ya Zhou; Hanqing Zou; Enhao Wu; Lei Huang; Rui Yin; Yuxin Mei; Xun Zhu
Journal:  Oncol Lett       Date:  2018-06-06       Impact factor: 2.967
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.